Blue Earth Therapeutics and Seibersdorf Expand Horizons
Blue Earth Therapeutics Expands Manufacturing Collaboration with Seibersdorf Labor Blue Earth Therapeutics, a subsidiary of Bracco, has expanded its...
What Does The Future Hold for RBQM in Clinical Trials?
In this interview, I speak with Duncan Hall, CEO of Tritrials, about the importance of Risk-Based Quality Management (RBQM)...
Advancing Drug Development: FDA’s Take on In Silico Trials
The Clinical Trial Transformation Initiative (CTTI) and the FDA hosted a workshop on Artificial Intelligence in Drug & Biological...
Unlocking Digital Endpoints: A New Era in Trials
In the rapidly evolving world of clinical trials, digital endpoints are emerging as critical components that enhance the precision...
Navigating the Complexities of Cell and Gene Therapy Manufacturing
The 2024 DIA conference, a session about gene therapy manufacturing chaired by Dr. Fouad Atouf, Senior Vice President of...
AN2 Therapeutics Fails Phase 2 Lung Trial
After releasing unfavorable results from the Phase 2 portion of the EBO-301 study, AN2 Therapeutics has decided to cease...
Humanetics Corp Partnership: Advancing Radiation Countermeasures
Humanetics Corporation and researchers from the Armed Forces Radiobiology Research Institute (AFRRI) have partnered to secure $3 million in...
Paige Partners with Microsoft to Introduce AI Models for Cancer
In partnership with Microsoft, Paige has introduced Virchow2 and Virchow2G, the latest generation of its AI foundation models for...
Tempus AI’s Precision Oncology Study Unveils Validated Hla-Loh Assay
Tempus AI, a leading company in applying AI to precision medicine, has published a study validating its investigational human...
DeepCure’s Groundbreaking AI-Generated Drug DC-9476
DeepCure, a biotechnology company leveraging AI for drug discovery, has unveiled its first development candidate, DC-9476. This third-generation BRD...